|Min SIP Amount||Not Supported|
|NAV||₹6.90 (06 Aug 2020)|
|Fund Started||18 Jan 2018|
|Fund Size||₹52 Cr|
|Bayer CropScience Ltd.||Healthcare||Equity||8.0%|
|Birla Corporation Ltd.||Construction||Equity||5.8%|
|CreditAccess Grameen Ltd.||Financial||Equity||5.2%|
|Bajaj Consumer Care Ltd.||FMCG||Equity||4.2%|
|Valiant organics Ltd||Healthcare||Equity||4.2%|
|Ion Exchange (India) Ltd.||Engineering||Equity||4.1%|
|JK Paper Ltd.||FMCG||Equity||3.6%|
|Indian Energy Exchange Ltd.||Financial||Equity||3.5%|
Nippon India Capital Builder Fund IV Series D Regular Growth is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 18 Jan 2018. Jahnvee Shah, Manish Gunwani, Meenakshi Dawar, Dhrumil Shah is the Current Fund Manager of Nippon India Capital Builder Fund IV Series D Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹52 Cr and the Latest NAV as of 06 Aug 2020 is ₹6.90.
The Nippon India Capital Builder Fund IV Series D Regular Growth is rated Moderately High risk.
The investment objective of the scheme is to provide capital appreciation to the investors, which will be in line with their long term savings goal, by investing in a diversified portfolio of equity & equity related instruments with small exposure to fixed income securities. Although, the objective of the Fund is to generate optimal returns, the objective may or may not be achieved.